Endocrine Society RPHR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this book
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manolagas, S.C.
Right arrow Articles by Jilka, R.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manolagas, S.C.
Right arrow Articles by Jilka, R.L.
Recent Progress in Hormone Research 57:385-409 (2002)
© 2002 The Endocrine Society

Sex Steroids and Bone

S.C. Manolagas, S. Kousteni and R.L. Jilka

Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, and the Central Arkansas Veterans Health Care System, Little Rock, Arkansas 72205

The adult skeleton is periodically remodeled by temporary anatomic structures that comprise juxtaposed osteoclast and osteoblast teams and replace old bone with new. Estrogens and androgens slow the rate of bone remodeling and protect against bone loss. Conversely, loss of estrogen leads to increased rate of remodeling and tilts the balance between bone resorption and formation in favor of the former. Studies from our group during the last 10 years have elucidated that estrogens and androgens decrease the number of remodeling cycles by attenuating the birth rate of osteoclasts and osteoblasts from their respective progenitors. These effects result, in part, from the transcriptional regulation of genes responsible for osteoclastogenesis and mesenchymal cell replication and/or differentiation and are exerted through interactions of the ligand-activated receptors with other transcription factors. However, increased remodeling alone cannot explain why loss of sex steroids tilts the balance of resorption and formation in favor of the former. Estrogens and androgens also exert effects on the lifespan of mature bone cells: pro-apoptotic effects on osteoclasts but anti-apoptotic effects on osteoblasts and osteocytes. These latter effects stem from a heretofore unexpected function of the classical "nuclear" sex steroid receptors outside the nucleus and result from activation of a Src/Shc/extracellular signal-regulated kinase signal transduction pathway probably within preassembled scaffolds called caveolae. Strikingly, estrogen receptor (ER) alpha or beta or the androgen receptor can transmit anti-apoptotic signals with similar efficiency, irrespective of whether the ligand is an estrogen or an androgen. More importantly, these nongenotropic, sex-nonspecific actions are mediated by the ligand-binding domain of the receptor and can be functionally dissociated from transcriptional activity with synthetic ligands. Taken together, these lines of evidence strongly suggest that, in sex steroid deficiency, loss of transcriptional effects may be responsible for the increased osteoclastogenesis and osteoblastogenesis and thereby the increased rate of bone remodeling. Loss of nongenotropic anti-apoptotic effects on mature osteoblasts and osteocytes, in combination with an opposite effect on the lifespan of mature osteoclasts, may be responsible for the imbalance between formation and resorption and the progressive loss of bone mass and strength. Elucidation of the dual function of sex steroid receptors has important pathophysiologic and pharmacologic implications. Specifically, synthetic ligands of the ER that can evoke the nongenotropic but not the genotropic signal may be bone anabolic agents, as opposed to natural estrogens or selective estrogen receptor modulators that are antiresorptive agents. The same ligands may also circumvent the side effects associated with conventional hormone replacement therapy.




This article has been cited by other articles:


Home page
 Ann. N. Y. Acad. Sci.Home page
B. A. CROMER
Menstrual Cycle and Bone Health in Adolescents
Ann. N.Y. Acad. Sci., June 1, 2008; 1135(1): 196 - 203.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. T. Page, B. T. Marck, J. M. Tolliver, and A. M. Matsumoto
Tissue Selectivity of the Anabolic Steroid, 19-Nor-4-Androstenediol-3{beta},17{beta}-Diol in Male Sprague Dawley Rats: Selective Stimulation of Muscle Mass and Bone Mineral Density Relative to Prostate Mass
Endocrinology, April 1, 2008; 149(4): 1987 - 1993.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Denger, T. Bahr-Ivacevic, H. Brand, G. Reid, J. Blake, M. Seifert, C.-Y. Lin, K. May, V. Benes, E. T. Liu, et al.
Transcriptome Profiling of Estrogen-Regulated Genes in Human Primary Osteoblasts Reveals an Osteoblast-Specific Regulation of the Insulin-Like Growth Factor Binding Protein 4 Gene
Mol. Endocrinol., February 1, 2008; 22(2): 361 - 379.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. L. McCarthy, R. B. Hochberg, D. C. Labaree, and M. Centrella
3-Ketosteroid Reductase Activity and Expression by Fetal Rat Osteoblasts
J. Biol. Chem., November 23, 2007; 282(47): 34003 - 34012.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. N. WEITZMANN and R. PACIFICI
T Cells: Unexpected Players in the Bone Loss Induced by Estrogen Deficiency and in Basal Bone Homeostasis
Ann. N.Y. Acad. Sci., November 1, 2007; 1116(1): 360 - 375.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. Grassi, G. Tell, M. Robbie-Ryan, Y. Gao, M. Terauchi, X. Yang, M. Romanello, D. P. Jones, M. N. Weitzmann, and R. Pacifici
Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation
PNAS, September 18, 2007; 104(38): 15087 - 15092.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Almeida, L. Han, M. Martin-Millan, L. I. Plotkin, S. A. Stewart, P. K. Roberson, S. Kousteni, C. A. O'Brien, T. Bellido, A. M. Parfitt, et al.
Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex Steroids
J. Biol. Chem., September 14, 2007; 282(37): 27285 - 27297.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
L. Penolazzi, M. Zennaro, E. Lambertini, E. Tavanti, E. Torreggiani, R. Gambari, and R. Piva
Induction of Estrogen Receptor {alpha} Expression with Decoy Oligonucleotide Targeted to NFATc1 Binding Sites in Osteoblasts
Mol. Pharmacol., June 1, 2007; 71(6): 1457 - 1462.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Q. Hassan, R. Tare, S. H. Lee, M. Mandeville, B. Weiner, M. Montecino, A. J. van Wijnen, J. L. Stein, G. S. Stein, and J. B. Lian
HOXA10 Controls Osteoblastogenesis by Directly Activating Bone Regulatory and Phenotypic Genes
Mol. Cell. Biol., May 1, 2007; 27(9): 3337 - 3352.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
L. Wang, Y.-D. Wang, W.-J. Wang, Y. Zhu, and D.-J. Li
Dehydroepiandrosterone improves murine osteoblast growth and bone tissue morphometry via mitogen-activated protein kinase signaling pathway independent of either androgen receptor or estrogen receptor
J. Mol. Endocrinol., April 1, 2007; 38(4): 467 - 479.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
M. Longo, B. Peruzzi, D. Fortunati, V. De Luca, S. Denger, G. Caselli, S. Migliaccio, and A. Teti
Modulation of human estrogen receptor {alpha} F promoter by a protein kinase C/c-Src-dependent mechanism in osteoblast-like cells
J. Mol. Endocrinol., December 1, 2006; 37(3): 489 - 502.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Yirmiya, I. Goshen, A. Bajayo, T. Kreisel, S. Feldman, J. Tam, V. Trembovler, V. Csernus, E. Shohami, and I. Bab
From the Cover: Depression induces bone loss through stimulation of the sympathetic nervous system
PNAS, November 7, 2006; 103(45): 16876 - 16881.
[Abstract] [Full Text] [PDF]

Home page
 Poult. Sci.Home page
K.-L. Chen, S.-M. Tsay, T.-Y. Lee, and P. W.-S. Chiou
Effects of caponization and different exogenous androgen on the bone characteristics of male chickens.
Poult. Sci., November 1, 2006; 85(11): 1975 - 1979.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. J. Allison, P. Baldock, A. Sainsbury, R. Enriquez, N. J. Lee, E.-J. D. Lin, M. Klugman, M. During, J. A. Eisman, M. Li, et al.
Conditional Deletion of Hypothalamic Y2 Receptors Reverts Gonadectomy-induced Bone Loss in Adult Mice
J. Biol. Chem., August 18, 2006; 281(33): 23436 - 23444.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Xin, M. A. Teitell, D. A. Lawson, A. Kwon, I. K. Mellinghoff, and O. N. Witte
Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor
PNAS, May 16, 2006; 103(20): 7789 - 7794.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. P. Bilezikian
What's Good for the Goose's Skeleton is Good for the Gander's Skeleton.
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1223 - 1225.
[Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
A. ZALLONE
Direct and Indirect Estrogen Actions on Osteoblasts and Osteoclasts
Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 173 - 179.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. N. WEITZMANN and R. PACIFICI
Estrogen Regulation of Immune Cell Bone Interactions
Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 256 - 274.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Almeida, L. Han, C. A. O'Brien, S. Kousteni, and S. C. Manolagas
Classical Genotropic Versus Kinase-Initiated Regulation of Gene Transcription by the Estrogen Receptor {alpha}
Endocrinology, April 1, 2006; 147(4): 1986 - 1996.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-Z. Liu, V. Dvornyk, Y. Lu, H. Shen, J. M. Lappe, R. R. Recker, and H.-W. Deng
A Novel Pathophysiological Mechanism for Osteoporosis Suggested by an in Vivo Gene Expression Study of Circulating Monocytes
J. Biol. Chem., August 12, 2005; 280(32): 29011 - 29016.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
J. Chen, J. Kim, and J. T. Dalton
Discovery and Therapeutic Promise of Selective Androgen Receptor Modulators
Mol. Interv., June 1, 2005; 5(3): 173 - 188.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Bonnelye and J. E. Aubin
Estrogen Receptor-Related Receptor {alpha}: A Mediator of Estrogen Response in Bone
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3115 - 3121.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. J. Perry, S. Gujra, T. Whitworth, and J. H. Tobias
Tamoxifen Stimulates Cancellous Bone Formation in Long Bones of Female Mice
Endocrinology, March 1, 2005; 146(3): 1060 - 1065.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-R. Chen, L. I. Plotkin, J. I. Aguirre, L. Han, R. L. Jilka, S. Kousteni, T. Bellido, and S. C. Manolagas
Transient Versus Sustained Phosphorylation and Nuclear Accumulation of ERKs Underlie Anti-Versus Pro-apoptotic Effects of Estrogens
J. Biol. Chem., February 11, 2005; 280(6): 4632 - 4638.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. J. Jagger, J. M. Lean, J. T. Davies, and T. J. Chambers
Tumor Necrosis Factor-{alpha} Mediates Osteopenia Caused by Depletion of Antioxidants
Endocrinology, January 1, 2005; 146(1): 113 - 118.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Gennari, R. Nuti, and J. P. Bilezikian
Aromatase Activity and Bone Homeostasis in Men
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5898 - 5907.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Gao, W.-P. Qian, K. Dark, G. Toraldo, A. S. P. Lin, R. E. Guldberg, R. A. Flavell, M. N. Weitzmann, and R. Pacifici
Estrogen prevents bone loss through transforming growth factor {beta} signaling in T cells
PNAS, November 23, 2004; 101(47): 16618 - 16623.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. W. Tomlinson, E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart
11{beta}-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response
Endocr. Rev., October 1, 2004; 25(5): 831 - 866.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Stossi, D. H. Barnett, J. Frasor, B. Komm, C. R. Lyttle, and B. S. Katzenellenbogen
Transcriptional Profiling of Estrogen-Regulated Gene Expression via Estrogen Receptor (ER) {alpha} or ER{beta} in Human Osteosarcoma Cells: Distinct and Common Target Genes for These Receptors
Endocrinology, July 1, 2004; 145(7): 3473 - 3486.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson
Androgens and Bone
Endocr. Rev., June 1, 2004; 25(3): 389 - 425.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
J. L. Turgeon, D. P. McDonnell, K. A. Martin, and P. M. Wise
Hormone Therapy: Physiological Complexity Belies Therapeutic Simplicity
Science, May 28, 2004; 304(5675): 1269 - 1273.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Toda, Y. Okada, M. Zubair, K.-i. Morohashi, T. Saibara, and T. Okada
Aromatase-Knockout Mouse Carrying an Estrogen-Inducible Enhanced Green Fluorescent Protein Gene Facilitates Detection of Estrogen Actions in Vivo
Endocrinology, April 1, 2004; 145(4): 1880 - 1888.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Thomas, P. Moffatt, P. Salois, M.-H. Gaumond, R. Gingras, E. Godin, D. Miao, D. Goltzman, and C. Lanctot
Osteocrin, a Novel Bone-specific Secreted Protein That Modulates the Osteoblast Phenotype
J. Biol. Chem., December 12, 2003; 278(50): 50563 - 50571.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. C. Farach-Carson and P. J. Davis
Steroid Hormone Interactions with Target Cells: Cross Talk between Membrane and Nuclear Pathways
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 839 - 845.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Moverare, J. Dahllund, N. Andersson, U. Islander, H. Carlsten, J.-A. Gustafsson, S. Nilsson, and C. Ohlsson
Estren Is a Selective Estrogen Receptor Modulator with Transcriptional Activity
Mol. Pharmacol., December 1, 2003; 64(6): 1428 - 1433.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
S. Kousteni, J.-R. Chen, T. Bellido, L. Han, A. A. Ali, C. A. O'Brien, L. Plotkin, Q. Fu, A. T. Mancino, Y. Wen, et al.
Reversal of Bone Loss in Mice by Nongenotropic Signaling of Sex Steroids
Science, October 25, 2002; 298(5594): 843 - 846.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by the The Endocrine Society.